Please provide your email address to receive an email when new articles are posted on . The mean time to treatment was 2.5 hours after presentation. Initial outcomes demonstrated significant ...

Central retinal artery occlusion (CRAO) is a sight‐threatening condition characterised by the abrupt interruption of blood flow to the retina. The resultant ischaemia precipitates sudden, painless ...

This Collection welcomes original research articles that explore clinical, translational and preclinical studies with a focus on pathophysiology, diagnostics, treatment and long-term outcomes. Retinal ...

ABU DHABI, UAE — Thrombolysis to treat central retinal artery occlusion, also known as “eye stroke,” appeared to improve visual acuity compared with oral aspirin but this did not reach statical ...

Please provide your email address to receive an email when new articles are posted on . The study included 418,965 patients (81.1% women) with two migraine diagnoses within 1 year of each other and at ...

In both studies, Vabysmo was found to be noninferior to aflibercept, with average vision gains being comparable between the treatment groups. The Food and Drug Administration (FDA) has approved ...

New research shows that a treatment for retinal vein occlusion yields long-lasting vision gains, with visual acuity remaining significantly above baseline at five years. However, many patients require ...

– Additional U.S. label update across indications includes information on rare post-marketing reports of retinal vasculitis and/or retinal vascular occlusion; reporting rate is in line with other ...

Each terminal choroidal arteriole supplies an independent lobule (segment) of the lamina choriocapillaris. Occlusion of these terminal arterioles produces a corresponding perfusion defect, and its ...

COVID-19 infection may be boosting the numbers of a rare ocular condition in which vision is threatened when veins in the retina are blocked, eye specialists in Southern California report. Risk of ...

DelveInsight’s “Retinal Vein Occlusion Pipeline Insight 2025” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Retinal Vein Occlusion pipeline landscape. It ...